Related Experiment Video
Updated: Jun 20, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Clostridum difficile associated disease in Latin America]
Adrián Camacho-Ortiz1, Alfredo Ponce-de-León, José Sifuentes-Osornio
1Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F., México.
Gaceta Medica De Mexico
|August 19, 2009
Summary
Few studies in Latin America address Clostridium difficile associated disease (CDAD). Antibiotic use, particularly fluoroquinolones, clindamycin, and cephalosporins, is linked to CDAD, with lower attributable mortality than in developed countries.
Area of Science:
- Infectious Diseases
- Epidemiology
- Microbiology
Context:
- Clostridium difficile associated disease (CDAD) incidence is rising globally.
- Latin America has limited research on CDAD clinical characteristics and risk factors.
- Existing studies often involve small sample sizes and retrospective designs.
Purpose:
- To review and synthesize existing literature on CDAD in Latin America.
- To identify common risk factors, clinical presentations, and treatment patterns.
- To highlight research gaps and the need for prospective studies in the region.
Summary:
- A literature review identified seven recent studies on CDAD in Latin America, primarily focusing on hospitalized adults.
- Fluoroquinolones, clindamycin, and cephalosporins were frequently associated with CDAD; metronidazole was a common treatment.
- Attributable mortality in reviewed studies was under 4%, significantly lower than reported in developed countries.
Impact:
- Identifies a critical need for more robust, prospective research on CDAD in Latin America.
- Provides a baseline understanding of CDAD epidemiology and risk factors in the region.
- Informs clinical practice and public health strategies for managing CDAD in Latin American healthcare settings.
Related Concept Videos
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...